rs146976883

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015602.4(TOR1AIP1):​c.70C>G​(p.Pro24Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00292 in 1,517,228 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P24R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0022 ( 3 hom., cov: 31)
Exomes 𝑓: 0.0030 ( 11 hom. )

Consequence

TOR1AIP1
NM_015602.4 missense

Scores

2
8
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 3.27

Publications

3 publications found
Variant links:
Genes affected
TOR1AIP1 (HGNC:29456): (torsin 1A interacting protein 1) This gene encodes a type 2 integral membrane protein that binds A- and B-type lamins. The encoded protein localizes to the inner nuclear membrane and may be involved in maintaining the attachment of the nuclear membrane to the nuclear lamina during cell division. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2016]
TOR1AIP1 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2Y
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007002741).
BP6
Variant 1-179882572-C-G is Benign according to our data. Variant chr1-179882572-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 476288.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00223 (340/152210) while in subpopulation NFE AF = 0.00348 (237/68006). AF 95% confidence interval is 0.00312. There are 3 homozygotes in GnomAd4. There are 168 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TOR1AIP1NM_015602.4 linkc.70C>G p.Pro24Ala missense_variant Exon 1 of 10 ENST00000606911.7 NP_056417.2 Q5JTV8-1
TOR1AIP1NM_001267578.2 linkc.70C>G p.Pro24Ala missense_variant Exon 1 of 10 NP_001254507.1 Q5JTV8-3
LOC139427322NM_001436163.1 linkc.*179C>G downstream_gene_variant NP_001423092.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TOR1AIP1ENST00000606911.7 linkc.70C>G p.Pro24Ala missense_variant Exon 1 of 10 1 NM_015602.4 ENSP00000476687.1 Q5JTV8-1
ENSG00000293564ENST00000713864.1 linkc.*179C>G downstream_gene_variant ENSP00000519169.1

Frequencies

GnomAD3 genomes
AF:
0.00224
AC:
340
AN:
152092
Hom.:
3
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00509
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00348
Gnomad OTH
AF:
0.00288
GnomAD2 exomes
AF:
0.00220
AC:
353
AN:
160708
AF XY:
0.00218
show subpopulations
Gnomad AFR exome
AF:
0.000537
Gnomad AMR exome
AF:
0.000810
Gnomad ASJ exome
AF:
0.00130
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00362
Gnomad NFE exome
AF:
0.00331
Gnomad OTH exome
AF:
0.00272
GnomAD4 exome
AF:
0.00300
AC:
4089
AN:
1365018
Hom.:
11
Cov.:
29
AF XY:
0.00298
AC XY:
1995
AN XY:
669738
show subpopulations
African (AFR)
AF:
0.000465
AC:
14
AN:
30126
American (AMR)
AF:
0.000779
AC:
22
AN:
28256
Ashkenazi Jewish (ASJ)
AF:
0.00324
AC:
64
AN:
19756
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38644
South Asian (SAS)
AF:
0.000400
AC:
28
AN:
70006
European-Finnish (FIN)
AF:
0.00324
AC:
157
AN:
48502
Middle Eastern (MID)
AF:
0.000389
AC:
2
AN:
5142
European-Non Finnish (NFE)
AF:
0.00342
AC:
3659
AN:
1068470
Other (OTH)
AF:
0.00255
AC:
143
AN:
56116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
248
496
745
993
1241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00223
AC:
340
AN:
152210
Hom.:
3
Cov.:
31
AF XY:
0.00226
AC XY:
168
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.000554
AC:
23
AN:
41540
American (AMR)
AF:
0.000653
AC:
10
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5156
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4816
European-Finnish (FIN)
AF:
0.00509
AC:
54
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00348
AC:
237
AN:
68006
Other (OTH)
AF:
0.00285
AC:
6
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00371
Hom.:
0
Bravo
AF:
0.00194
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000229
AC:
1
ESP6500EA
AF:
0.00223
AC:
19
ExAC
AF:
0.00211
AC:
249
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ENSG00000272906: BS2; TOR1AIP1: BS2 -

May 06, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2Y Benign:3
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Apr 08, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.70C>G (p.P24A) alteration is located in exon 1 (coding exon 1) of the TOR1AIP1 gene. This alteration results from a C to G substitution at nucleotide position 70, causing the proline (P) at amino acid position 24 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

TOR1AIP1-related disorder Benign:1
Apr 01, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.14
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.43
.;.;T
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.87
D;D;D
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.0070
T;T;T
MetaSVM
Benign
-0.67
T
MutationAssessor
Benign
2.0
M;.;M
PhyloP100
3.3
PrimateAI
Uncertain
0.63
T
PROVEAN
Uncertain
-3.1
D;D;.
REVEL
Benign
0.16
Sift
Pathogenic
0.0
D;D;.
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
1.0
.;.;D
Vest4
0.56
MVP
0.72
MPC
0.51
ClinPred
0.034
T
GERP RS
5.3
PromoterAI
0.17
Neutral
Varity_R
0.47
gMVP
0.17
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146976883; hg19: chr1-179851707; COSMIC: COSV99056338; COSMIC: COSV99056338; API